Merck Serono Invests RMB 300 Million To Establish Chinese Branch
This article was originally published in PharmAsia News
Executive Summary
Showing confidence in the future of China's prescription drug market, Merck Serono recently announced plans to invest RMB 300 million to establish a branch in China